EDN1 and endothelial dysfunction: In patients with IR, the pathway-specific impairment of phosphatidylinositol 3-kinase–dependent signaling may result in an imbalance between the production of nitric oxide and the secretion of endothelin-1, which leads to endothelial dysfunction (44).